Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China · Delayed Price · Currency is CNY 2.660
+0.030 (1.14%)
Aug 26, 2026, 12:54 PM CST
SHE:002622 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 703.25 | 702.83 | 861.13 | 756.62 | 500.6 | 167.98 |
Other Revenue | 0.07 | 0.07 | 0.44 | 0.09 | 0.05 | 0.13 |
| 703.32 | 702.9 | 861.57 | 756.71 | 500.65 | 168.11 | |
Revenue Growth | -11.33% | -18.42% | 13.86% | 51.14% | 197.82% | 47.02% |
Cost of Revenue | 362.1 | 390.36 | 445.21 | 371.42 | 292.54 | 91.1 |
Gross Profit | 341.22 | 312.54 | 416.36 | 385.29 | 208.11 | 77 |
Selling, General & Admin | 321.63 | 322.22 | 353.1 | 296.4 | 262.75 | 72.53 |
Research & Development | 8.96 | 11.76 | 10.11 | 15.9 | 14.57 | 9.85 |
Other Operating Expenses | -0.71 | -0.95 | -1.84 | -2.93 | -2.42 | -1.58 |
Operating Expenses | 330.67 | 330.94 | 364.74 | 311.88 | 277.74 | 81.44 |
Operating Income | 10.55 | -18.41 | 51.63 | 73.42 | -69.64 | -4.44 |
Interest Expense | -23.85 | -39.43 | -41.55 | -44.63 | -62.6 | -38.82 |
Interest & Investment Income | - | - | - | 19.96 | 12.43 | 1.23 |
Other Non Operating Income (Expenses) | -16.89 | -0.33 | -2.16 | -3.56 | -3.41 | -0.31 |
EBT Excluding Unusual Items | -30.04 | -58.17 | 7.92 | 45.19 | -123.21 | -42.34 |
Impairment of Goodwill | -14.35 | -14.35 | - | - | -21.19 | -14.72 |
Gain (Loss) on Sale of Investments | -40.23 | -40.23 | -3.7 | -91.79 | 66.39 | -17.43 |
Gain (Loss) on Sale of Assets | 0.03 | 0.71 | -0.58 | 4.17 | 0.88 | 0.03 |
Asset Writedown | -0.61 | -0.61 | -0.21 | -0.1 | -0.1 | - |
Legal Settlements | -13.42 | -13.42 | -13.46 | -13.42 | -215.27 | - |
Other Unusual Items | 2.36 | 0.15 | 0.74 | 1.84 | 2.56 | 4.59 |
Pretax Income | -96.26 | -125.92 | -9.29 | -54.11 | -289.94 | -69.86 |
Income Tax Expense | 4.4 | 4.01 | 5.95 | 4.15 | -9.73 | 3.97 |
Earnings From Continuing Operations | -100.66 | -129.93 | -15.24 | -58.26 | -280.22 | -73.83 |
Minority Interest in Earnings | -9.04 | 10.5 | -22.45 | -36.11 | 23.43 | -2.15 |
Net Income | -109.7 | -119.42 | -37.69 | -94.37 | -256.79 | -75.98 |
Net Income to Common | -109.7 | -119.42 | -37.69 | -94.37 | -256.79 | -75.98 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 840 | 840 | 839 | 840 | 840 | 844 |
Shares Outstanding (Diluted) | 840 | 840 | 839 | 840 | 840 | 844 |
Shares Change | -2.73% | 0.04% | -0.10% | 0.03% | -0.50% | 0.50% |
EPS (Basic) | -0.13 | -0.14 | -0.04 | -0.11 | -0.31 | -0.09 |
EPS (Diluted) | -0.13 | -0.14 | -0.04 | -0.11 | -0.31 | -0.09 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 83.41 | 44.12 | 78.57 | 103.4 | 8.26 | 12.63 |
Free Cash Flow Per Share | 0.10 | 0.05 | 0.09 | 0.12 | 0.01 | 0.01 |
Gross Margin | 48.52% | 44.46% | 48.33% | 50.92% | 41.57% | 45.81% |
Operating Margin | 1.50% | -2.62% | 5.99% | 9.70% | -13.91% | -2.64% |
Profit Margin | -15.60% | -16.99% | -4.38% | -12.47% | -51.29% | -45.20% |
Free Cash Flow Margin | 11.86% | 6.28% | 9.12% | 13.66% | 1.65% | 7.51% |
EBITDA | 28.68 | -1.84 | 69.25 | 91.12 | -50.55 | 7.57 |
EBITDA Margin | 4.08% | -0.26% | 8.04% | 12.04% | -10.10% | 4.50% |
D&A For EBITDA | 18.14 | 16.57 | 17.62 | 17.71 | 19.09 | 12.01 |
EBIT | 10.55 | -18.41 | 51.63 | 73.42 | -69.64 | -4.44 |
EBIT Margin | 1.50% | -2.62% | 5.99% | 9.70% | -13.91% | -2.64% |
Revenue as Reported | 389.26 | 702.9 | 861.57 | 756.71 | 500.65 | - |
Advertising Expenses | - | 109.4 | 115.09 | 104.5 | 94.22 | 8.15 |